Ute Galm
Impact in
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
- Toxicology top 5%
Papers in
-
- Cancer therapeutics and mechanisms 5
- Chemical Synthesis and Analysis 3
- Genomics and Phylogenetic Studies 2
- Biochemical and Molecular Research 2
- Pharmacology 14
- Microbial Natural Products and Biosynthesis 14
- Co-authors
- Ben Shen (13 shared papers)Martin H. Hager (2 shared papers)Steven G. Van Lanen (2 shared papers)Jianhua Ju (2 shared papers)Jon S. Thorson (2 shared papers)Lutz Heide (5 shared papers)Meifeng Tao (9 shared papers)Jane M. Coughlin (9 shared papers)
- Journals
- Molecular BioSystems (3 papers)Journal of Natural Products (2 papers)Journal of Biological Chemistry (2 papers)The Journal of Antibiotics (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Ute Galm
19 papers receiving 1.3k citations
Ute Galm's Hit Papers
Peers
Comparison fields: 5 of 82
- Pharmacology 575
- Toxicology 71
- Biotechnology 152
- Organic Chemistry 473
- Molecular Biology 703
Countries citing papers authored by Ute Galm
This map shows the geographic impact of Ute Galm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Galm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Galm more than expected).
Fields of papers citing papers by Ute Galm
This network shows the impact of papers produced by Ute Galm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Galm. The network helps show where Ute Galm may publish in the future.
Co-authors
The 25 scholars most cited alongside Ute Galm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin Hit paper breakdown → | 2005 | 505 |
| 2 | 2005 | 86 | |
| 3 | 2004 | 84 | |
| 4 | 2002 | 77 | |
| 5 | 2004 | 64 | |
| 6 | 2015 | 64 | |
| 7 | 2007 | 57 | |
| 8 | 2011 | 55 | |
| 9 | 2006 | 52 | |
| 10 | 2006 | 51 | |
| 11 | 2008 | 49 | |
| 12 | 2007 | 41 | |
| 13 | 2012 | 40 | |
| 14 | 2008 | 35 | |
| 15 | 2009 | 19 | |
| 16 | 2014 | 11 | |
| 17 | 2004 | 8 | |
| 18 | 2009 | 7 | |
| 19 | 2005 | 2 |
About Ute Galm
Ute Galm is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Biotechnology and Toxicology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (14 papers), Cancer therapeutics and mechanisms (5 papers), Bioactive Compounds and Antitumor Agents (3 papers), Chemical Synthesis and Analysis (3 papers), Cyclization and Aryne Chemistry (2 papers), Genomics and Phylogenetic Studies (2 papers), Microbial Metabolism and Applications (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Pharmacology (575 citations), Toxicology (71 citations), Biotechnology (152 citations), Organic Chemistry (473 citations) and Molecular Biology (703 citations). Ute Galm has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Ben Shen, Martin H. Hager, Steven G. Van Lanen, Jianhua Ju, Jon S. Thorson, Lutz Heide, Meifeng Tao, Jane M. Coughlin, Evelyn Wendt-Pienkowski and Thomas C. Sparks. Their work appears in journals such as Molecular BioSystems, Journal of Natural Products, Journal of Biological Chemistry, The Journal of Antibiotics and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.